Chemocentryx (CCXI) Shareholder Carmignac Gestion Upped Its Holding by $3.30 Million; Citigroup Stake in Domtar (UFS) Has Cut as Valuation Declined

Domtar Corporation (NYSE:UFS) Logo

Carmignac Gestion increased its stake in Chemocentryx Inc (CCXI) by 26.83% based on its latest 2018Q3 regulatory filing with the SEC. Carmignac Gestion bought 275,273 shares as the company’s stock declined 9.75% with the market. The institutional investor held 1.30M shares of the health care company at the end of 2018Q3, valued at $16.45 million, up from 1.03 million at the end of the previous reported quarter. Carmignac Gestion who had been investing in Chemocentryx Inc for a number of months, seems to be bullish on the $544.67M market cap company. The stock increased 0.28% or $0.03 during the last trading session, reaching $10.78. About 267,474 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 69.59% since March 2, 2018 and is uptrending. It has outperformed by 69.59% the S&P500. Some Historical CCXI News: 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 09/03/2018 – ChemoCentryx 4Q Net $39.7M; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/05/2018 – CHEMOCENTRYX INC – EXPECTS TO UTILIZE CASH AND INVESTMENTS BETWEEN $65 MLN AND $75 MLN FOR TWELVE MONTHS ENDING DECEMBER 31, 2018

Citigroup Inc decreased its stake in Domtar Corp (UFS) by 64.72% based on its latest 2018Q3 regulatory filing with the SEC. Citigroup Inc sold 26,334 shares as the company’s stock declined 23.92% with the market. The institutional investor held 14,355 shares of the paper company at the end of 2018Q3, valued at $749,000, down from 40,689 at the end of the previous reported quarter. Citigroup Inc who had been investing in Domtar Corp for a number of months, seems to be less bullish one the $3.23 billion market cap company. The stock increased 0.73% or $0.37 during the last trading session, reaching $51.28. About 1.04 million shares traded or 17.45% up from the average. Domtar Corporation (NYSE:UFS) has declined 17.82% since March 2, 2018 and is downtrending. It has underperformed by 17.82% the S&P500. Some Historical UFS News: 27/04/2018 – Domtar Corporation Gives Away Free Tree Seedlings to the Ashdown, AR Community to Celebrate Earth Week; 15/05/2018 – Domtar Corporation & Nonprofit Partner, First Book, Give Grant for New Books to Riverview Elementary in Fort Mill, SC; 01/05/2018 – Domtar 1Q EPS 86c; 12/04/2018 – Media Advisory: Domtar Corporation First Quarter 2018 Financial Results; 23/04/2018 – DJ Domtar Corporation, Inst Holders, 1Q 2018 (UFS); 09/05/2018 – Domtar Corporation & Nonprofit Partner, First Book, Give Grant for New Books to Eastern Elementary School in Greenville, NC; 24/04/2018 – Domtar Corporation & Nonprofit Partner, First Book, Give Grant to Ashdown Elementary School for New Books; 08/03/2018 Domtar Improves the Paper Trail, Providing Increased Supply Chain Transparency for Pulp and Paper Products; 26/04/2018 – Domtar Corporation & Nonprofit Partner, First Book, Give Grant for New Books to Rapoport Academy Elementary in Waco, TX; 28/03/2018 – Domtar Corporation & Nonprofit Partner, First Book, Give Grant to Kimball Elementary School for New Books

Carmignac Gestion, which manages about $11.80B US Long portfolio, decreased its stake in Albemarle Corp (NYSE:ALB) by 5,200 shares to 1.31 million shares, valued at $130.43 million in 2018Q3, according to the filing. It also reduced its holding in Agnico Eagle Mines Ltd (NYSE:AEM) by 1.72 million shares in the quarter, leaving it with 3.15 million shares, and cut its stake in Cara Therapeutics Inc (NASDAQ:CARA).

Investors sentiment decreased to 0.98 in Q3 2018. Its down 0.61, from 1.59 in 2018Q2. It dropped, as 14 investors sold CCXI shares while 29 reduced holdings. 13 funds opened positions while 29 raised stakes. 26.80 million shares or 1.64% more from 26.37 million shares in 2018Q2 were reported. Public Employees Retirement System Of Ohio, Ohio-based fund reported 99,284 shares. D E Shaw holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 259,837 shares. Moreover, Los Angeles Capital Mgmt And Equity Research Inc has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 23,932 shares. Dekabank Deutsche Girozentrale holds 20,000 shares or 0% of its portfolio. Dorsey Wright And Associates reported 975 shares or 0% of all its holdings. Strs Ohio stated it has 52,400 shares. Dimensional Fund Advsrs Lp has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Landscape Capital Management Limited Liability Co invested 0.01% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Adams Diversified Equity Fund holds 40,200 shares. Partners Limited Liability Company has invested 0.01% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Clarivest Asset Mngmt Limited Liability Corp holds 0.01% or 53,100 shares. Moreover, J Goldman And Co Ltd Partnership has 0.03% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 32,500 shares. Ameritas Prtn owns 2,120 shares. Bnp Paribas Arbitrage stated it has 738 shares or 0% of all its holdings. Fincl Bank Of New York Mellon Corporation reported 126,848 shares or 0% of all its holdings.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Seekingalpha.com which released: “ChemoCentryx withdraws conditional approval application for avacopan in Europe – Seeking Alpha” on January 24, 2019, also Nasdaq.com with their article: “ChemoCentryx to Present at the 8th Annual SVB Leerink Global Healthcare Conference – Nasdaq” published on February 20, 2019, Seekingalpha.com published: “ChemoCentryx (CCXI) CEO Thomas Schall on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” on November 08, 2018. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Seekingalpha.com and their article: “Chemocentryx secures $20M capital raise – Seeking Alpha” published on January 31, 2019 as well as Globenewswire.com‘s news article titled: “ChemoCentryx Announces Proposed Public Offering of Common Stock – GlobeNewswire” with publication date: September 26, 2018.

Since October 16, 2018, it had 0 insider buys, and 8 sales for $87.64 million activity. Cappel Markus J. had sold 13,203 shares worth $158,790. 20,170 shares valued at $242,370 were sold by Schall Thomas J. on Monday, January 7. GLAXOSMITHKLINE PLC had sold 7.34M shares worth $85.85 million on Tuesday, October 16.

More notable recent Domtar Corporation (NYSE:UFS) news were published by: Seekingalpha.com which released: “Stocks To Watch: Those Ticking Clocks – Seeking Alpha” on February 09, 2019, also Seekingalpha.com with their article: “Stocks To Watch: Spotlight On Walmart, Samsung And CAGNY – Seeking Alpha” published on February 16, 2019, 247Wallst.com published: “Top Analyst Upgrades and Downgrades: DowDuPont, Electronic Arts, Estee Lauder, Exxon, Generac, Match, Nasdaq, Novartis, PayPal, Snap, Vishay and More – 24/7 Wall St.” on February 06, 2019. More interesting news about Domtar Corporation (NYSE:UFS) were released by: Prnewswire.com and their article: “Aurora Cannabis Announces Financial Results for the Second Quarter of Fiscal 2019 – PRNewswire” published on February 11, 2019 as well as Seekingalpha.com‘s news article titled: “Domtar records operating income gain – Seeking Alpha” with publication date: February 05, 2019.

Since February 13, 2019, it had 0 buys, and 1 insider sale for $580,733 activity.

Investors sentiment decreased to 1.14 in 2018 Q3. Its down 0.12, from 1.26 in 2018Q2. It dropped, as 27 investors sold UFS shares while 83 reduced holdings. 35 funds opened positions while 90 raised stakes. 54.67 million shares or 2.52% less from 56.08 million shares in 2018Q2 were reported. Fairpointe Capital Ltd Llc reported 2.31% stake. Commonwealth Of Pennsylvania Pub School Empls Retrmt has invested 0.01% of its portfolio in Domtar Corporation (NYSE:UFS). Bailard invested 0.04% of its portfolio in Domtar Corporation (NYSE:UFS). Dekabank Deutsche Girozentrale holds 0.04% in Domtar Corporation (NYSE:UFS) or 131,122 shares. Geode Cap Management Lc has 1.18M shares for 0.02% of their portfolio. Arizona State Retirement System reported 44,659 shares. State Treasurer State Of Michigan reported 0.01% stake. Ellington Mngmt Ltd Liability Company has invested 0.09% of its portfolio in Domtar Corporation (NYSE:UFS). Quantbot Technology Ltd Partnership holds 0.06% of its portfolio in Domtar Corporation (NYSE:UFS) for 15,409 shares. South Dakota Invest Council invested 0.02% in Domtar Corporation (NYSE:UFS). Lpl Ltd stated it has 5,961 shares or 0% of all its holdings. Jefferies Gru Ltd has invested 0.01% in Domtar Corporation (NYSE:UFS). Laurion LP has 18,826 shares. Guggenheim Cap Ltd Liability Com accumulated 127,616 shares. Acadian Asset Ltd Liability owns 0.33% invested in Domtar Corporation (NYSE:UFS) for 1.51 million shares.

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart


Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *